news
Synerkine Pharma and NorthX Biologics sign manufacturing alliance
Synerkine Pharma today announced a manufacturing alliance with NorthX Biologics AB, a leading biopharmaceutical company committed to pioneering solutions in gene therapy and biotechnology.
Synerkine Pharma appoints Industry Veteran Anders Ekblom to its Board of Directors
Synerkine Pharma today announced the appointment of industry veteran Anders Ekblom, MD, PhD, DDS as a new Member of its Board of Directors.
Synerkine Pharma secures EUR 12.1 million to accelerate novel pain therapeutics towards clinical proof-of-concept
Synerkine Pharma today announced an extension of its Series A financing and a matching innovation credit from Rijksdienst voor Ondernemend (RVO) Nederland - the Netherlands Enterprise Agency.
Synerkine adds New members to advisory board
Dr. Frank Luyten and Dr. Mienke Rijsdijk, both experienced pain specialists, joined as new members of Synerkine’s advisory board.
Emilie Rodrigues joins Synerkine Pharma
Synerkine Pharma is excited to welcome Emilie Rodrigues as the latest member to the team.
Synerkine Pharma announces Series A extension
Synerkine Pharma raises EUR 3.5 million in an extended Series A financing. The extension was led by Flerie Invest.
Synerkine collaboration partner receives LSH-TKI grant
Dr. Mastbergen from the University Medical Center Utrecht has been awarded a grant for a collaborative effort with Synerkine Pharma…